Publication | Open Access
Comparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes
271
Citations
12
References
2007
Year
Vildagliptin is an effective and well-tolerated treatment option in patients with type 2 diabetes, demonstrating similar glycemic reductions as rosiglitazone but without weight gain.
| Year | Citations | |
|---|---|---|
Page 1
Page 1